Tinted IOL demonstrates no significant changes in contrast and sensitivity

Article

Using an ultraviolet (UV) and blue-light filtering IOL presents no significant changes in scotopic and photopic contrast sensitivity, and colour perception.

Using an ultraviolet (UV) and blue-light filtering IOL presents no significant changes in scotopic and photopic contrast sensitivity, and colour perception, according to a study published in the Journal of Cataract and Refractive Surgery.

A prospective, randomized clinical study led by Dr Marcony R. Santhiago, Ophthalmology Department, University of São Paulo, Brazil, consisted of 60 eyes of 30 patients with bilateral visually significant cataract.

Each patient was fitted with a UV and blue-light filtering IOL in one eye (Acrysof Natural SN60AT) and a UV-only IOL (Acrysof SA60AT) in the fellow eye. The primary outcome measures included scotopic and photopic contrast sensitivity, colour vision and macular findings. All measurements were taken 5 years postoperatively.

The results demonstrated no significant optical coherence tomography (OCT) findings with regards to age-related macular degeneration. Also, there were no significant differences between the groups in terms of photopic and scotopic contrast sensitivity.

Additional studies are required to identify the potential advantages of using tinted IOLs for the protection of macular cells.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.